GLP-1 reconstitution: identify the product before doing anything
Reconstitution means adding a specified liquid to a powder. It is product-specific—not a universal GLP-1 step.
Direct answer
What you need to know
Evidence strength: StrongDo not use an online recipe to reconstitute or measure a GLP-1 product. FDA-approved pens and many approved vials arrive ready to use. If a licensed pharmacy supplied a powder or multi-dose vial, use only that pharmacy’s written directions and resolve any missing or conflicting detail with the pharmacist before injecting.
Key takeaways
- First determine whether the product is FDA-approved, compounded, or sold as a research chemical.
- Concentration, vial size and syringe markings are separate pieces of information.
- “Units” on a syringe are not milligrams of medication.
- A damaged seal, unclear label, particles, discoloration or missing instructions means stop and contact the dispenser.
Important limitation: This page cannot safely provide a mixing volume or dose conversion because those depend on the exact, verified product and prescription.
Next action: Read the full label and contact the dispensing pharmacist for a demonstration if any concentration, storage, preparation or syringe instruction is unclear.
Primary sources: U.S. Food and Drug Administration, U.S. Food and Drug Administration
Never inject a product labeled only for research use or not for human consumption.
If you may have measured or injected the wrong amount
Contact your prescriber, pharmacist, Poison Control in the United States (1-800-222-1222), or urgent medical services for individualized advice. Call emergency services for severe symptoms, fainting, difficulty breathing, confusion or inability to stay awake.
Why a universal reconstitution guide would be unsafe
Products may arrive in different forms and concentrations. FDA has reported adverse events, some requiring hospitalization, after errors with compounded injectable semaglutide—including confusion between millilitres, milligrams and syringe “units.” A worked conversion copied from another vial can therefore produce the wrong dose.
Clinician-discussion checklist
Bring the medication container or label and ask:
- What exact product and concentration have I received?
- Is it FDA-approved, compounded, or an unapproved research product?
- What written storage and preparation instructions apply to this specific container?
- Which measuring device should I use, and can you show me how its units relate to my prescription?
- What should I do if the liquid looks different, the seal is damaged, or I miss a dose?
- Which symptoms mean I should stop and seek care?
Learning path
Identify and use safely
- Start hereDosing and titration
Understand why labeled schedules and gradual escalation matter.
- Injection sites and rotation
Review approved injection areas and sharps disposal after product instructions are clear.
Understand adjacent risks
- Research compounds
Learn why a research-use label is not a route to human treatment.
- Side-effect decision guide
Separate mild effects from symptoms needing prompt assessment.
Next: understand labeled dosing and titration.
Sources
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
- FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide productsU.S. Food and Drug AdministrationSupports: Dosing errors involving differing concentrations, vial-and-syringe measurement, and unit confusion.
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight LossU.S. Food and Drug AdministrationSupports: Differences between FDA-approved, compounded, and other unapproved GLP-1 products.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.